Maximus (NYSE: MMS) saw its full fiscal year 2022 revenue rise 8.9 percent to $4.63 billion and reported $3.29 in
In the last three years, the U.S. health care system has undergone dramatic changes, catalyzed by the global COVID-19 pandemic,
Maximus’ (NYSE: MMS) move to purchase Veterans Evaluation Services, a Houston-based facilitator of medical disability compensation and pension exams, for
Logistics Health and Medical Support Los Angeles: A Medical Corporation have won spots on a potential $6.8 billion contract vehicle to update the
The Department of Veterans Affairs has awarded three companies positions on a potential five-year, $6.8 billion contract vehicle to process
